This topic contains a solution. Click here to go to the answer

Author Question: If one measures the voltage potential of a presynaptic neuron and a postsynaptic neuron that form a ... (Read 76 times)

lidoalex

  • Hero Member
  • *****
  • Posts: 538
If one measures the voltage potential of a presynaptic neuron and a postsynaptic neuron that form a synapse,
 
  the magnitude of the potential measured at the postsynaptic membrane is typically ___________________ ___ the potential measured at the presynaptic membrane when an action potential arrives at the presynaptic neuron's axon terminal.
  a. larger than b. smaller than c. equal to

Question 2

When chemically (ligand) gated channels open and allow negatively charged ions (e.g., chloride, Cl-) to enter a neuron in the dendrites or cell body, the consequence is
 
  a. a decrease in the neuron's excitability (i.e., its tendency to create an action potential)
  b. an increase in the neuron's excitability (i.e., its tendency to create an action potential)
  c. to create an action potential



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

annierak

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

b

Answer to Question 2

a




lidoalex

  • Member
  • Posts: 538
Reply 2 on: Jun 22, 2018
Excellent


ricroger

  • Member
  • Posts: 352
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library